The Use of Thrombin Generation Assay in Detection of Central Line Related Thrombosis (CRT) in Critically Ill Patients

NCT06094387 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2024-04-09

No results posted yet for this study

Summary

To study thrombin generation parameters in critically ill patients with and without central line related thrombosis (CRT).

Conditions

  • Central Line Complication
  • Thrombosis, Venous

Interventions

DIAGNOSTIC_TEST

Thrombin generation assay

Thrombin generation parameters in patients receiving central catheter insertion

Sponsors & Collaborators

  • Queen Mary Hospital, Hong Kong

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-06
Primary Completion
2024-12-01
Completion
2025-04-01

Countries

  • Hong Kong

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06094387 on ClinicalTrials.gov